Companies · Other Health Care

KAIO Therapy, LLC

RALEIGH · Other Health Care

Diligence memoA one-page analyst read on KAIO Therapy, LLC — recommendation, valuation, rhythm, risks.
$3.9M
Total raised · real
3
Rounds
4.5×
Latest step-up
Top 41%
Sector rank · raised
Seed
Latest stage · inferred · Fri Sep 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

KAIO Therapy, LLC looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.56× the median modeled value of Seed Other Health Care companies in 2019–2021 (211 peers) — value vs value, same stage and era.
Dormant
  • Last raise 5.8 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

KAIO Therapy, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
12.5 yr record
Peak capital year was 2013 with $2.8M across 1 filings.
Market position
ahead of 60% of Other Health Care peers
Capital scale is ahead of 60% of Other Health Care peers; modeled value is above 48% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2013: $2.8M across 1 filings.
  • Largest single filing was $2.8M on 2013-12-31.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

KAIO Therapy, LLC is one of 5377 Other Health Care companies tracked from RALEIGH. By capital raised it ranks mid-pack (ahead of 60% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
12
Investors (latest)
2020-09-25
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$25M$50M$75M$100MSeed · 2013-12-31 Raised $2.8M (real) Modeled valuation $70M (est)$2.8M$70MSeed2013Seed · 2016-09-14 Raised $200K (real) Modeled valuation $5.0M (est)$200K$5.0MSeed2016Seed · 2020-09-25 Raised $897K (real) Modeled valuation $20M (est)$897K$20MSeed2020+$200K+$897KCumulative $3.9M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$2.8M · 2013
Seed extension$200K · 2016
Seed extension$897K · 2020

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.

Modeled valuation trajectory
$20.1M
Base estimate est.
$759K
Conservative case
$148.1M
Upside case
$4.5M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Seed · modeled $69.7M · 2013-12-312013Seed · modeled $5.0M · 2016-09-14Seed · modeled $20.1M · 2020-09-252020
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
38%
Survival probability
17% low · 58% high
1.54×/yr
Annual markup
2.01×/yr upside case
5.8 yr
Elapsed time used
5.8 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
40 mo
Avg between rounds
$581K/yr
Capital velocity
12.5 yr
On record since
2013
First round
3
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 1.6× above median
This company$3.9M
Sector median$2.4M
Latest round — vs other Seed rounds in sector (real $, this stage) 0.5× of median
This company$897K
Sector median$1.7M
Modeled value — vs sector median (estimate, all stages) 0.9× of median
This company$20.1M
Sector median$22.1M

Raised more than 60% of sector peers (real $). Modeled value above 48% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #169 of 211.

This companyCohort peer
$10.0M$100.0M$1.0B$1.0M$10.0MCapital raised (log)Crossroads at Delta Memory · Seed Raised $4.3M · modeled $99.1M (est)Noninvasix, Inc. · Seed Raised $4.0M · modeled $97.9M (est)CPIV Haven Holdings, LLC · Seed Raised $3.8M · modeled $92.9M (est)Cane Ip Key Holdings, Llc · Seed Raised $3.5M · modeled $87.4M (est)Hospi Corp · Seed Raised $7.0M · modeled $86.6M (est)Functional Fluidics Inc. · Seed Raised $3.6M · modeled $84.2M (est)Starling Solutions Inc. · Seed Raised $3.8M · modeled $82.2M (est)CairnSurgical, Inc. · Seed Raised $3.3M · modeled $81.5M (est)DxLab Inc. · Seed Raised $4.0M · modeled $81.5M (est)Freedom Center of Beacon, LLC · Seed Raised $3.2M · modeled $80.5M (est)GenomOncology, LLC · Seed Raised $5.8M · modeled $79.3M (est)Kingwood Surgicenter, LLC · Seed Raised $3.0M · modeled $74.7M (est)KAIO Therapy, LLC (this company) Raised $3.9M · modeled $20.1M (est)KAIO Therapy, LLC
CompanyStageRaised · realValue · estvs peer med.
Crossroads at Delta MemorySeed$4.3M$99.1M2.77×
Noninvasix, Inc.Seed$4.0M$97.9M2.73×
CPIV Haven Holdings, LLCSeed$3.8M$92.9M2.60×
Cane Ip Key Holdings, LlcSeed$3.5M$87.4M2.44×
Hospi CorpSeed$7.0M$86.6M2.42×
Functional Fluidics Inc.Seed$3.6M$84.2M2.35×
Starling Solutions Inc.Seed$3.8M$82.2M2.30×
CairnSurgical, Inc.Seed$3.3M$81.5M2.28×
DxLab Inc.Seed$4.0M$81.5M2.28×
Freedom Center of Beacon, LLCSeed$3.2M$80.5M2.25×
GenomOncology, LLCSeed$5.8M$79.3M2.22×
Kingwood Surgicenter, LLCSeed$3.0M$74.7M2.09×
KAIO Therapy, LLC this companySeed$3.9M$20.1M0.56×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$2.8M2013-12-31$14.1M$69.7M85%
Seed$200K2016-09-14$1.0M$5.0M85%
Seed$897K2020-09-25$4.5M$20.1M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$2.8M2013-12-31
    • First recorded raise — entered as Seed.
    • 1 investor on this round.
  2. Seed$200K2016-09-14
    • Raised again after 32 mo — slower than the ~14 mo sector norm.
    • Round 14.1× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  3. Seed$897K2020-09-25
    • Raised again after 48 mo — slower than the ~14 mo sector norm.
    • Round 4.5× larger than the prior — scaling up.
    • 12 investors on this round.
Intelligence
2024 ~Q1
Modeled next raise · ~40mo cadence
$2.7M
Modeled next size est.range $1.7M$4.3M
4.5×
Last step-up
$581K/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
WILLIAM PHILLIP HODGES3 other2016-09
PETER GEIGER1 other2020-09
Alden Pritchard2013-12
Peter P Geiger2013-12
Peter Phillip Geiger2016-09
William Hodges2020-09
William P Hodges2013-12
Registry & provenance

KAIO Therapy, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1596199
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Chesson Laboratory Associates IncOther Health CareSeed$5.2M$9.4Mnetwork1 shared operator · same sector · same stage
Perfusio Corp.Other Health CareSeries A$16.4M$9.3Mnetwork2 shared operators · same sector
MedTrust Holdings, Inc.Other Health CareSeed$3.9M$23.9Msame sector · same stage
ThermalTherapeutic Systems, Inc.Other Health CareSeed$3.8M$20.0Msame sector · same stage
Arche Inc.Other Health CareSeed$4.0M$19.5Msame sector · same stage
MelioLabs, Inc.Other Health CareSeed$4.0M$17.8Msame sector · same stage
OHEADS Propco Holdings LLCOther Health CareSeed$4.0M$18.0Msame sector · same stage
Themedicalmemory, LlcOther Health CareSeed$3.8M$19.7Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Kairos BioMedical, Inc.Other Health CarePre-Seed$5.4M89%
Akos MD, LLCOther Health CareSeed$36.7M83%
Phyto Management LLCOther Health CarePre-Seed$13.9M82%
Caipa Mso, LlcOther Health CareSeries A$102.9M82%
Therapydia, Inc.Other Health CareSeries A$43.2M82%
Tc Mso, Inc.Other Health CareSeries A$100.9M81%
Emerging Therapy Solutions, Inc.Other Health CareSeries A$26.9M81%
Diamdmso, LLCOther Health CarePre-Seed$8.2M81%
Frequently asked
How much funding has KAIO Therapy, LLC raised?
KAIO Therapy, LLC has raised approximately $3.9M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is KAIO Therapy, LLC's estimated valuation?
Provath's modeled valuation for KAIO Therapy, LLC is approximately $20.1M (modeled range $759K–$148.1M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is KAIO Therapy, LLC at?
KAIO Therapy, LLC's latest modeled financing stage is Seed. Its most recent recorded round closed around Fri Sep 25.
What does KAIO Therapy, LLC do and where is it based?
KAIO Therapy, LLC operates in the Other Health Care sector, based in RALEIGH.
Explore related

See where KAIO Therapy, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at KAIO Therapy, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.